G&S Capital LLC Vertex Pharmaceuticals Inc Transaction History
G&S Capital LLC
- $218 Million
- Q1 2024
A detailed history of G&S Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, G&S Capital LLC holds 689 shares of VRTX stock, worth $338,726. This represents 0.13% of its overall portfolio holdings.
Number of Shares
689
Previous 697
1.15%
Holding current value
$338,726
Previous $283,000
1.77%
% of portfolio
0.13%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding VRTX
# of Institutions
1,626Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.6 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$11.1 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.9 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.49 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...